Amicogen Revenue

In the year 2024, Amicogen had annual revenue of 173.60B KRW with 8.57% growth. Amicogen had revenue of 56.85B in the quarter ending December 31, 2024, with 45.82% growth.

Revenue

173.60B

Revenue Growth

+8.57%

P/S Ratio

1.14

Revenue / Employee

771.58M

Employees

225

Market Cap

196.79B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	173.60B	13.70B	8.57%
Dec 31, 2023	159.90B	15.61B	10.82%
Dec 31, 2022	144.30B	19.41B	15.55%
Dec 31, 2021	124.88B	9.02B	7.79%
Dec 31, 2020	115.86B	675.18M	0.59%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,547.32B
Celltrion	3,557.30B
ALTEOGEN	102.85B
Yuhan	2,067.79B
SK Biopharmaceuticals	547.60B
HLB Co., Ltd.	51.92B
Sam Chun Dang Pharm.	210.92B
PharmaResearch	350.12B

Revenue Rankings